Evidence map›Paper›PMID 40963922›Full record

ArticleTheranostics2025

Aptamer-based drug delivery for targeted therapy of imatinib-resistant gastrointestinal stromal tumor.

Tao Pan, Ming Wang, Linxi Yang, Yihan Zheng, Yuanding Liu, Yu Xiao, Xudong Qiu, Yanying Shen, Mahan Dawuren, Zhiqiang Ren and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Tao PanDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Ming WangDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Linxi YangDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Yihan ZhengDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Yuanding LiuDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Yu XiaoDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Xudong QiuDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Yanying ShenDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Mahan DawurenDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Zhiqiang RenDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Keying LiuDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Yang SunDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Lin TuDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Hui CaoDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
Weihong TanDepartment of Gastrointestinal Surgery, Institute of Molecular Medicine (IMM), Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsAptamers, NucleotideDrug Delivery SystemsDrug Resistance, NeoplasmGastrointestinal NeoplasmsGastrointestinal Stromal TumorsImatinib MesylateAnimalsCell Line, TumorHumansMiceProto-Oncogene Proteins c-kitXenograft Model Antitumor AssaysAntineoplastic AgentsAptamers, NucleotideImatinib MesylateProto-Oncogene Proteins c-kitaptamer-drug conjugategastrointestinal stromal tumorimatinib resistanceKITtumor-targeted therapy

Identifiers

PMID40963922
PMCPMC12439145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.